European Journal of Clinical Pharmacology

, Volume 74, Issue 5, pp 671–672 | Cite as

Advantage of landiolol over esmolol? We doubt it!

  • Guenther Frank
  • Robert Denham Fitzgerald
Letter to the Editor


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.


  1. 1.
    Krumpl G, Ulc I, Trebs M, Kadlecova P, Hodisch J (2017) Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol 73(4):417–428. CrossRefPubMedGoogle Scholar
  2. 2.
    Nasrollahi-Shirazi S, Sucic S, Yang Q, Freissmuth M, Nanoff C (2016) Comparison of the beta-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions. J Pharmacol Exp Ther 359(1):73–81. CrossRefPubMedGoogle Scholar
  3. 3.
    Shibata S, Okamoto Y, Endo S, Ono K (2012) Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J Pharmacol Sci 118(2):255–265CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Anaesthesia and Intensive Care MedicineLandesklinikum HornHornAustria
  2. 2.Karl Landsteiner Institute for Anaesthesiology and Intensive Care MedicineViennaAustria

Personalised recommendations